前置胎盘剖宫产术中预防性髂内动脉球囊阻断不能减少产后出血:一项随机对照试验
该随机对照试验纳入40例34周诊断前置胎盘并需剖宫产的孕妇,比较髂内动脉球囊阻断与标准管理。意向性分析显示两组术中出血量中位数、手术时间及输血需求均无显著差异,且无并发症发生。结论认为预防性髂内动脉球囊阻断未能减少产后出血或改善母儿结局。
要点
- 预防性髂内动脉球囊阻断未降低前置胎盘剖宫产产后出血。
- 两组术中出血量、手术时间和输血需求无显著差异。
- 未观察到与髂内动脉操作相关的并发症或母体并发症。
核心结论
- 前置胎盘剖宫产术中预防性髂内动脉球囊阻断未减少产后出血,对母儿发病率无影响。
研究设计与样本
- 前瞻性随机对照试验,在香港三级大学产科单位进行,2016年5月至2018年9月随机40例孕妇,每组20例。
主要发现
- 无术后再出血、髂内动脉操作相关并发症或其他母体并发症。
- 符合方案分析结果与意向性分析一致。
关键数值与推荐
- 前置胎盘定义为34周时胎盘下缘距宫颈内口2 cm以内。
- 球囊阻断组在剖宫产前放置髂内动脉球囊导管,娩出胎儿后充盈球囊。
临床怎么用
- 对于前置胎盘剖宫产,预防性髂内动脉球囊阻断不推荐用于减少产后出血。
局限性
- 样本量小(共40例),可能不足以检测较小差异。
- 球囊阻断组有3例因产前出血紧急剖宫产未接受预定操作,1例36周复查胎盘边缘超过2 cm。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Placenta previa remains one of the major causes of massive postpartum hemorrhage and maternal mortality worldwide. OBJECTIVE: To determine whether internal iliac artery balloon occlusion during cesarean delivery for placenta previa could reduce postpartum hemorrhage and other maternal complications. STUDY DESIGN: This was a prospective randomized controlled trial conducted at a tertiary university obstetric unit in Hong Kong. Pregnant women who were diagnosed to have placenta previa at 34 weeks (defined as lower placenta edge within 2 cm from the internal os) and required cesarean delivery were invited to participate. Eligible pregnant women were randomized into internal iliac artery balloon occlusion (Occlusion) group or standard management (Control) group. Those randomized to the Occlusion group had internal iliac artery balloon catheter placement performed before cesarean delivery and then balloon inflation after delivery of the baby. The primary outcome was the reduction of postpartum hemorrhage in those with internal iliac artery balloon occlusion. Secondary outcome measures included hemoglobin drop after delivery; amount of blood product transfusion; incidence of hysterectomy; maternal complications including renal failure, ischemic liver, disseminated intravascular coagulation, and adult respiratory distress syndrome; length of stay in hospital; admission to intensive care unit; and maternal death. RESULTS: Between May 2016 and September 2018, 40 women were randomized (20 in each group). Demographic and obstetric characteristics were similar between the 2 groups. In the Occlusion group, 3 women did not receive the scheduled procedure, as it was preceded by antepartum hemorrhage that required emergency cesarean delivery, and 1 woman had repeated scan at 36 weeks showing the placental edge was slightly more than 2 cm from the internal os. Intention-to-treat analysis found no significant differences between the Occlusion and the Control groups regarding to the median intraoperative blood loss (1451 [1024-2388] mL vs 1454 [888-2300] mL; P = .945), the median length of surgery (49 [30-62] min vs 37 [30-51] min; P = .204), or the need for blood transfusion during operation (57.9% vs 50.0%; P = .621). None of the patients had rebleeding after operation, complication related to internal iliac artery procedure, or any other maternal complications. Reanalyzing the data using on-treatment approach showed the same results. CONCLUSION: The use of prophylactic internal iliac artery balloon occlusion in placenta previa patients undergoing cesarean delivery did not reduce postpartum hemorrhage or have any effect on maternal or neonatal morbidity.
引用
- Yu SCH, Cheng YKY, Tse WT, et al. Perioperative prophylactic internal iliac artery balloon occlusion in the prevention of postpartum hemorrhage in placenta previa: a randomized controlled trial. Am J Obstet Gynecol. 2020. PMID: 31978436. doi:10.1016/j.ajog.2020.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。